Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies

Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies

Prostate cancer is among most malignant tumors around the world and this urological tumor can be developed as result of genomic mutations and their accumulation during progression towards advanced stage. Due to lack of specific symptoms in early stages of prostate cancer, most cancer patients are di...

Full description

Bibliographic Details
Main Authors: Mehrdad Hashemi, Mohammad Arad Zandieh, Yasmin Talebi, Parham Rahmanian, Sareh Sadat Shafiee, Melina Maghsodlou Nejad, Roghayeh Babaei, Farzaneh Hasani Sadi, Romina Rajabi, Zahra Oryan Abkenar, Shamin Rezaei, Jun Ren, Noushin Nabavi, Ramin Khorrami, Mohsen Rashidi, Kiavash Hushmandi, Maliheh Entezari, Afshin Taheriazam
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Prostate cancer
Paclitaxel
Docetaxel
Chemoresistance
Targeted delivery
Plant derived-natural compounds
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223001804

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223001804

Similar Items